A B S T R A C T 16 patients underwent renal transplanitation from a sibling donor who was prospectively determiiined to be ABO compatible and HL-A identical with the recipient. Unidirectional mixed leukocyte reactions were performed; in each instance, lymphocyte stimulation in either directi.on was not observed.
ml/min, and the blood urea nitrogen (BUN) ranged between 12 and 35 mg/100 ml. Urine protein excretion varied from 0.11 to 1.86 g/day. Six patients exhibited no detectable clinical episodes of acute rejection; they were treated with azathioprine alone and each of them demonstrated normal or near normal renal histology when biopsy specimens were obtained more than 6 months after transplantation. Nine patients experienced acute rejection episodes that required the use of steroid therapy. The severity of these rejection episodes was variable; they included a mild reduction in renal function with an immediate steroid-induced restorationi of function anid eventual discontinuance of steroid therapy to severe reduction in function requiring prolonged and moderate doses of steroids without return to normal renal function. Renal histological observations in this group ranged from mild to marked cellular and structural changes which fit the criteria of the rejection. One patient demonstrated a gradual loss of renal function with heavy proteinuria. Biopsy of this allograft demonstrated the recurrence of original disease. i.e.. lobular glomerulonephritis.
INTRODUCTION
Initial efforts in histocompatibility testing before renal transplantation have been directed toward the definition of donor-recipient compatibility for the major transplantation antigens with the hope that the adverse clinical expressions of minor incompatibilities might be controlled by immunosuppressive therapy (1) . It was established quite early that the red cell isoantigens A and B provided at least one major determinant of histocompatibility and that donor-recipient incompatibility for the minor red cell isoantigens was of lesser importance (2) . Conmplete donor-recipient compatibility for all surface membrane-associated tissue isoantigens would be difficult if not impossible to achieve (except among monozygotic twins), and identification of major antigenic differences between a single donor-recipient pair was recognized as the most that might be achieved realistically.
The genetic loci of the major histocompatibility antigens in man have now been identified and partially defined utilizing serologic techniques (3) (4) (5) (6) . Present data indicate that this antigenic system designated HL-A, is controlled by two closely linked polymorphic loci on a single pair of autosomal chromosomes. The first locus (lefines a series of HL-A antigens which includes HL-Al, 2, 3, 9, 10, and 11. A second series, controlled by the second locus, includes HL-A 5, 7, 8, 12, and 13 (7) . Studies within individual families indicate that a single HL-A antigen is defined by each of the two loci of a single chromosome. The complete HL-A genotype of any individual is therefore composed of four antigens defined by the corresponding first and second loci of the chromosomal pair, the contribution to the genotype by the two loci on a single chromosome being defined as the haplotype.' The immunogenicity of individual HL-A antigens
has not yet been evaluated completely. However, within a family group, HL-A compatibility between any siblingsibling or parental-offspring combination can be classified as HL-A identical, different by one HL-A haplotype, or different by both HL-A haplotypes. A positive correlation between these genetic relationships and the survival of test skin grafts exchanged within families has been demonstrated previously (8) .
Further, numerous early studies suggested that the mixed leukocyte reaction provided an in vitro measure of antigenic differences under the control of the HL-A loci (9) (10) (11) . It has been generally accepted that the HL-A antigens, the mixed leukocyte reaction, and the immuniological rejection of an allograft are the expression of the same locus. The validity of this statement has been challenged recently by the observation of anomalous mixed leukocyte reactivity between HL-A identical pairs as well as in situations where recombination for the HL-A loci was known to have occurred (12) (13) (14) . These findings have led Yunis and Amos (15) to suggest that HL-A antigens, the mixed leukocyte reaction, and hypersensitivity delayed reaction may represent the expression of separate but closely linked genetic loci.
It now seems certain that the HL-A loci provide a major determinant of histocompatibility in man. Nevertheless, further studies are needed to assess the role of non-HL-A and other membrane-associated antigenic systems in the determination of histocompatibility, and to identify and define the genetic loci of such factors. Clinical evaluation of the results of renal transplantation between HL-A identical donor-recipient pairs should provide valuable insight into the nlature of such factors. facilitate our understaniding of the importance of single ion-HL-A loci, and permit the detection of possible synergism between two or more non-HL-A loci as shown previously in the mouse non-H-2 system (16).
This report describes clinical observations on 16 patients who underwent renal transplantation after HL-A identity with their respective liv.ing donors was established by serotyping, the mixed leukocyte reaction, and the exchange of test skin grafts betweein selected family pairs. Clinical observations on the structure and function 1 Haplotype refers to the contribution of one member of a pair of homologous chromosomal units to the genotype. of the renal allograft were made for varying periods of time after renal transplantation in an effort to establish the nature and intensity of non-HL-A determinants of histocompatibility and the relationships between HL-A -identity, the subsequent clinical course, and alterations of renal structure and function. METHODS 16 patients with primary renal disease and chronic uremia and their potential living related donors underwent complete histocompatibility testing before renal transplantation; in each instance, serotypic evidence of HL-A identity was established between the recipient and a medically acceptable and willing donor. The potential recipients ranged in age from 16 to 52 yr; 14 patients were male, and 2 were multiparous females. All recipients had been followed closely at either the Duke Medical Center or the Durham Veterans Administration Hospital for 1-10 months. Each of them required repetitive hemodialysis for periods as long as 25 wk immediately before transplantation. Overall, based on an amalgam of clinical evidence (including morphologic examination of the recipient kidneys after bilateral nephrectomy at the time of transplantation), a diagnosis of chronic glomerulonephritis was made in 13 recipients, malignant nephrosclerosis in 2 recipients, and chronic pyelonephritis in one recipient.
Living donors were selected from olne or more siblings of each recipient. The selected sibling donors ranged between 20 and 47-yr of age; 5 were female and 11 were male.
In addition to histocompatibility evaluation, each selected donor underwent complete medical and psychiatric evaluation to determine his or her suitability. All were informed and willing volunteers. The specific details of donor selection at our institution have been outlined previously (17 (18) . Inheritance of the two HL-A haplotypes from each parental pair was established by haplotype analysis (8) .
Test skin grafts (4 mm in diameter) were exchanged between selected family pairs by a method described previously (1) . A skin graft was considered rejected when less than 50% of the transplanted tissue was viable by gross and microscopic examination. The exchange of these skin grafts among members of an individual family was designed to measure the immunogenicity of each of the HL-A haplotypes within the family, as well as that of non-HL-A loci that have not yet been defined. Test skin grafts were not placed on any of the potential recipients.
Unidirectional mixed leukocyte cultures were establishe(d between each sibling donor and recipient using the previously described technique. Appropriate controls were also used (19) .
Clinical m-anagemtent and evaluation after transplantation. Renal transplantation was carried out as soon as possible after the medical and immunological suitability of potential donor-recipient pairs had been established. The surgical details of the transplantation procedure itself have been described previously (20) ; pretransplantation transurethral resection of the prostate was performed in one male re- Surgical specimens. The recipient kidneys and the biopsy specimens from the allografts were evaluated by light, electron, and immunofluorescence microscopy. Each surgical specimen was divided into three portions. One portion was fixed in buffered 10% formalin, and processed in standard fashion for routine light microscopy. Sections were stained (Table III) .
Assessment of mixed leukocyte reactivity between the leukocytes of selected donor-recipient pairs failed to demonstrate stimulation in either direction. Nevertheless, the leukocytes of both the recipient and donor al- 27 -113 ml/min) after an average follow-up period of 33 months (range: 10-68 months). Furthermore, detectable episodes of acute rejection were never experienced by 6 of the 16 patients; hence, 27% of the recipients have never required any type of immunosuppression other than azathioprine. In addition, even in those patients who did experience one or more episodes of suspected acute rejection, such episodes were usually delayed in onset (average onset: 134 days after transplantation), mild in nature (maximal Pcr equaled 2.7+SD 1.97 m/G100 ml), and easily controlled by the administration of prednisone. Over-all, for the entire group, the average maintenance dose of prednisone at 6 and 12 months post-transplantation was only 12 awl(I 11 mg/day, respectively, and full-time occupational rehabilitation was achieved in 94% of the patients within 6 months. The functional status of individual allografts at sequential points in time is summarized in Table V . The maximum rise in BUN and Pcr, the minimal 24 hr urine output, and the duration of prednisone administration with the rejection episodes are included in Table VI .
Despite the satisfactory nature of these overall results, evaluation of individual patients revealed considerable heterogeneity in terms of the post-transplantation clinical course, the functional response of the allograft, and the attendant morphologic alterations in the biopsy specimens of the allografts.
Each of the 16 recipients was placed in one of three distinct clinical groups; each of these groups represents BUN in mg/100 ml; Pcr, (plasma creatinine) in mg/100 ml; Ccr, (creatinine clearance) in ml/min; U. Prot., (urinary protein) in g/day.
--it, (Figs. 3 and 4) .
Allograft morphology. Follow-up biopsies of the allograft were performed on two occasions: the first in January 1969, and the second in April 1970. The observed abnormalities in the initial biopsy were judged to have progressed at the time of the second biopsy. The glomerular basement membrane at the time of the first biopsy was slightly thickened, and rare, small, and local EDD were seen (Figs. 5 and 6 ). Immunoglobulin and complement localization were not observed; however, the interstitium contained a minor mononuclear cell exudate which was localized between an artery and a vein. The second renal biopsy specimen displayed glomerular changes of approximately the same intensity as those noted at first; nevertheless, limited, local, and granular deposits of IgG, 7S immunoglobulins, IgM (Fig. 7) , human complement, and fixation of guinea pig complement could be identified within the glomeruli at this time.
Clinical course. Initial immunosuppression consisted of azathioprine alone; however, on the 34th PTD the patient exhibited a deterioration in renal function that was interpreted as acute rejection. The reduction of Ccr responded only moderately to the institution of prednisone therapy. 3 months postoperatively, follow-up intravenous urography demonstrated a moderate degree of urinary obstruction, a ureteral pyeloplasty was carried out with satisfactory technical results. Despite early difficulties with rejection, urinary tract obstruction, and a persistent urinary tract infection, the BUN has remained stable between 18 and 24 mg/100 ml. Most recently, the Pcr has been 1.5 mg/100 ml, and the Ccr has equaled 77 ml/min without significant quantitative proteinuria (Table V) .
Two of the nine recipients developed an apparent episode of acute rejection very early after transplantation; the clinical events suggested the presence of performed recipient antibodies which reacted with donor antigens. High-dose steroid therapy was required, a marked and sustained loss of allograft function occurred, and histological examination of the allografts revealed the presence of several features which suggested that humoral immunity was involved in the rejection process. One of the two patients demonstrated cytotoxic antibody in his pretransplant serum sample. His clinical history follows.
Patient 0. M. (family 0184). This 42-yr old male was admitted with an 18 month history of progressive renal insufficiency. Important complications included severe hypertension and recurrent pericarditis with effusion; the latter required pericardiectomy 6 months before transplantation. The patient underwent bilateral nephrectomy and renal transplantation in March 1970. Histological examination of the recipient's kidneys revealed glomerulonephritis. Intramembranous EDD, glomerular deposits of IgG, IgM, and C'3 were identified as were local granular glomerular capillary deposits. Azathioprine alone was administered during the early postoperative course. However, on the 7th PTD the Pcr rose from 1.1 to 1.6 mg/100 ml and the Ccr fell from 65 to 52 ml/min. At this point high dose prednisone therapy was instituted wxhich gave a reduction in the Pcr, however, the Ccr remained in the range of 40-60 nl/mi/m. Proteinuria was approximately 1 g/day.
An arteriogramii on the 14th PTD revealed irregular cortical margins compatible with diffuse small vessel occlusioni. The patient was placed on heparin therapy without response.
Allograft morphology. The first biopsy of the allograft was performed in April 1970, approximately 1 montlh after transplantation. The tissue showed areas of acute cortical necrosis presumably secondary to homogenous eosinophilic masses of fibrin occluding many small renal vessels (Fig. 8) . Similar deposits were observed within the tufts of many renal glomeruli (Figs. 9, 10) . IgM, fibrinogen, and less intense staining for IgG and C'3 could be identified in isolated "thrombotic" glomerular capillary lesions. These changes were felt to reflect thromlbonecrotic changes suggestive of a humoral ele- and glomeruli which had presumably derived from resolution of the process that was observed in the first biopsv specimen. However, the predominant picture was that of normal renal tissue (Table I) .
Clintical course. At the present time, 1 yr after transplantation, the Ccr is 75 ml/min, the BUN is 16 mg/ 100 ml, and the Pcr is 1.5 mg/100 ml. There is no significant proteinuria (Table V) (Figs. 11, 12 ). At operation, after removal of the vascular clamps, the kidney remained soft and with evidence of poor flow and demonstrated persistent oliguria. The Pcr leveled off in the range of 2 mg/100 ml and the Ccr was in the range of 50 mil/min with proteinuria (3-5 g/day).
The clinical impression at the time was that the impaired renal function was secondary to acute tubular and cortical necrosis. The patient was treated with azathioprine alone until the 363rd PTD at which time a reduction in Ccr from 50 to 40 ml/min, and a rise in Pcr from 1.9 to 2.3 mg/100 ml were noted. Prednisone was instituted in high doses and subsequently tapered until PTD 560 at whiclh time the patient was receiving 20 mg daily.
Allogr-aft ilorpliology. The allograft was biopsied in January 1968 (616 PTD) and revealed distinctive lobular proliferative glomerulonephritis involving all glomeruli in a pattern identical with that observed originally in the host kidneys (Figs. 13 and 14) . Round cell infiltrates were evident in focal areas of the interstitium all with interstitial fibrosis which could be interpreted as representing acute rejection. Arterial and arteriolar changes of the type associated with chronic rejection were not evident, however. Local globular deposits of TgAM were found in isolated glomerular capillary loops (Table I) .
Clinical coutrse. The patient's renal function diminished progressively despite treatment with steroids and azathioprine, the Ccr was 10 ml/min on PTD 596 Table V (19) suggests that, in its present form, the MLR is not the most sensitive or reliable method of predicting genetic compatibility for human transplants, or that linkage equilibrium exists between the HL-A and MLR loci.
The present experience indicates that transplantation between HL-A identical subjects is not always heralded by uniformly good results. The fact that the six patients in group 1 did not exhibit discernible episodes of rejection or require steroid therapy clearly reflects the close degree of histocompatibility between these particular donor-recipient pairs. Three additional patients (in group 2) who exhibited acute rejection and required steroid therapy maintained near normal renal function after complete discontinuance of steroids. They demonstrated clinical changes suggestive of a mild immune response similar to that one might suspect in the presence of major loci compatibility and no more than a few minor incompatibilities. Two additional patients in group 2 have had similar clinical courses and are being maintained on 7 and 3 mg/day of steroids, respectively. The relatively normal histology of the allografts in these five patients, as well as the six patients in group 1 reflects the close genetic compatibility. The relatively early and more severe rejection episodes seen in two other recipients from group 2 suggests the presence of synergism or summation between numerous incompatibilites at non-HL-A loci. These two individuals demonstrated moderate to marked histologic changes of rejection in their allografts.
The sustained loss of renal function correlated with the severity of the observed histologic findings.
The very early and severe rejection episodes in the two re,naining patients in group 2 strongly points to the probability of previous sensitization leading to pre-existing immunity in the recipient to donor antigens. The latter case indeed demonstrated a cytotoxic antibody in his pretransplant serum that reacted with lymphocytes from 23 of 60 unrelated donors. The significance of a positive lymphocytotoxicity cross match in transplantation has been reported by Patel and Terasaki (27) as well as others, however, a hyperacute type response can be observed with a negative lymphocvtotoxicity crossmatch between recipient serum and donor cells (28) . A negative lymphocyte lysis is interpretable only within the limitations of this complement-dependent serological test and immune adherance utilizing kidney cells, or mixed agglutination, or leuko-agglutination may indicate a positive cross-match in the same donor-recipient pair and prospectively predict a hvperacute rejection. The diffuse thrombosis in the allograft as noted in this case (Fig. 8) was in keeping with a humoral immune response as has been reported by others (29, 30) . However, the fact that the lesions resolved with resultant vascular damage and little evidence of diminished renal function indicates that this case was not typical of classical hyperacute rejection.
The variability of the severity of the histological manifestations of rejection suggests further that other non-HL-A loci are important determinants of histocompatibilitv. In no instance were the morphologic changes in these patients as severe as those reported by others. Although repeat biopsy examination in one patient (patient 0117) suggested that histological damage had progressed, it was not felt that the observed changes were sufficient to lead to loss of function in this allograft.
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